• Datametrex’s (DM) Medi-Call telehealth subsidiary has expanded into Ontario and Alberta
  • The expansion was motivated by current shortages in healthcare availability across Canada
  • Management is confident that the expansion will improve the company’s healthcare revenue and profits
  • CEO Marshall Gunter sat down with Daniella Atkinson to discuss the expansion
  • Datametrex AI is a technology-focused company with a prominent footprint in artificial intelligence and machine learning
  • Datametrex (DM) opened trading at $0.07 per share

Datametrex’s (DM) Medi-Call telehealth subsidiary has expanded into Ontario and Alberta.

Medi-Call is a subscription-based software-as-a-service mobile app that connects patients with physicians in real-time. Its services include general and preventative care, urgent care, mental health services and prescriptions.

Individuals in Ontario and Alberta can now access the app for iOS and Android.

The expansion was motivated by current shortages in healthcare availability across Canada. 

Additionally, the Canadian Medical Association found that 91 per cent of Canadian patients were satisfied with virtual care, while 46 per cent prefer it as the first point of contact with their doctor.

Management is confident that the expansion will improve the company’s healthcare revenue and profits.

Medi-Call was first launched in British Columbia in June 2022.

CEO Marshall Gunter sat down with Daniella Atkinson to discuss the expansion.

“The rise in health care wait times are at an all-time high. Expanding our telehealth services is one way Datametrex plans to provide a solution to bring more accessible care to those who need it. “With our recent news of acquiring Imagine Health Centres and the expansion of our telehealth services with Lucira, the company is one step closer to providing simplified, timely health care to those who need it.”

Datametrex AI is a technology-focused company with a prominent footprint in artificial intelligence and machine learning. Its solutions address unmet needs in cybersecurity, telehealth and electric vehicles.

Datametrex (DM) opened trading at $0.07.


More From The Market Online

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.

BlackBerry expands AI-powered cybersecurity service

BlackBerry (TSX:BB) releases the new and expanded CylanceMDR, a managed detection and response tool backed by its Cylance AI platform.

Qualcomm stock jumps on Q2 2024 earnings

Qualcomm (NDAQ:QCOM) shares rise nearly 10 per cent early Thursday on better-than-expected adjusted earnings and strong revenue guidance.

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.